Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface

(2012) A. Leonardi et al.   ALLERGY

Structural and Functional Alteration of Corneal Epithelial Barrier Under Inflammatory Conditions

(2012) Laura Contreras-Ruiz et al.   CURRENT EYE RESEARCH

Ophthalmic antihistamines and H1–H4 receptors

(2012) Laurie Wade et al.   Current Opinion in Allergy and Clinical Immunology

The safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis

(2011) Gail Torkildsen et al.   CURRENT MEDICAL RESEARCH AND OPINION

Epidemiology of allergic conjunctivitis

(2011) Nelson Rosario et al.   Current Opinion in Allergy and Clinical Immunology

The epidemiology of ocular and nasal allergy in the United States, 1988-1994

(2010) Kavita Singh et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children

(2009) Mark B. Abelson et al.   CLINICAL THERAPEUTICS

Role of histamine H4 receptor in allergic conjunctivitis in mice

(2009) Yoshiyuki Nakano et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The histamine H4 receptor antagonist JNJ7777120 induces increases in the histamine content of the rat conjunctiva

(2009) E. Zampeli et al.   INFLAMMATION RESEARCH

Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood

(2007) Bengt Björkstén et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY